Novaestiq
Southlake, US · Founded 2021 · Delaware corporation
Founders & leadership
ER
Ethan RigelNamed on SEC filing
HA
Humberto AntunesNamed on SEC filing
MD
Miles David HarrisonNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$7.4M disclosed across 2 rounds · 2021
▶$7.4MraisedApr 2024 · 56 investors · Other Health CareRule 506(b)
▶$7.4MraisedApr 2024 · 56 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Miles David HarrisonExecutive Officer, Director
- Humberto AntunesExecutive Officer, Director
- Ethan RigelExecutive Officer
- Offering amount
- $10M
- Amount sold
- $7.4M
- Placement agents
- Issuer Direct Sales Only
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$28KraisedOct 2021 · 1 investors · Other Health CareRule 506(b)
▶$28KraisedOct 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ethan RigelExecutive Officer
- Humberto AntunesExecutive Officer, Director
- Miles David HarrisonExecutive Officer, Director
- Offering amount
- $28K
- Amount sold
- $28K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Novaestiq raised?
- Novaestiq has disclosed $7.4M raised across 2 rounds.
- Where is Novaestiq headquartered?
- Novaestiq is headquartered in Southlake, US.